Tag: Statins
Statins Safe, Effective in Rheumatoid Arthritis Patients
However, cardiovascular event rates are low, do not require a primary prevention strategy for all patients
Over Half of Patients Have Suboptimal Response to Statins
Suboptimal responders have increased risk for incident cardiovascular disease
Many Eligible Patients Report Not Being Offered Statins
Fear of side effects, perceived side effects most common reasons for declining, discontinuing statins
Statins Cut Risk for Major Vascular Events in Older Patients
Effects seen even among patients older than 75 years, though with less direct evidence of benefit
Statins Tied to Insulin Resistance, Higher Serum Fasting Insulin
Ever use of statins associated with 38 percent increased risk for incident type 2 diabetes
ACC: Adherence to Statins Low Among Patients With ASCVD
Adherence linked to significantly reduced risk for MACE, but only 6.4 percent had optimal compliance
Statin Therapy Reduces Risk for Diabetic Retinopathy in T2DM
Reduced risk, slowed progression of retinopathy for Taiwanese patients with type 2 diabetes, dyslipidemia
Adherence and Intensity of Lipid-Lowering Tx Influence CV Risk
Lowest risk seen for adherent patients receiving high-intensity statin and/or ezetimibe regimen
AHA Scientific Statement: Low Risk of Side Effects for Statins
Risk for statin-induced serious muscle injury <0.1 percent, newly diagnosed diabetes ~0.2 percent
Onset of Musculoskeletal Adverse Events Varies Between Statins
Significantly faster onset with atorvastatin, rosuvastatin versus simvastatin during monotherapy
